The function of the Protein Production Shared Resource (PPSR) is to stimulate and support interdisciplinary research among Cancer Center members and translate discoveries in the molecular and cellular biology of cancer to the disciplines of biochemistry, structural biology and chemical biology. The importance of protein science in Cancer Center research will grow in the post-genomic era. Pure proteins are essential for progress and the Protein Production Shared Resource is a focus of expertise and equipment for providing Cancer Center investigators at St. Jude Cancer Center access to these vital reagents. The PPSR employs state-ofthe- art technology to produce proteins and protein domains in large quantities for detailed biochemical and structural analysis. Efficient protein purification is facilitated by contemporary high-resolution chromatography systems, and the facility is equipped with automated crystallization screening equipment. The PPSR services are divided into four modules: (a) subcloning open reading frames into expression vectors; (b) expression of tagged proteins in a bacterial system; purification of the protein product; and (d) preliminary crystallization trials. We accept genes cloned into an appropriate vector for expression in bacterial systems. The protein is then purified by affinity, size exclusion and/or anion exchange chromatography. Crystallization trials are initiated using a CyberLab Robotic workstation. Crude extracts may also be submitted for purification of the protein of interest, or a pure protein submitted for crystallization trials. The resource is designed to be a high throughput facility, focused on performing achievable goals. The projected total budget for this Shared Resource in Year-25 of this grant is $426,268, of which 26% ($112,053) is requested from the CCSG; the remainder of the budget (74%, $314,215) will be provided by SJCRH institutional funds and by chargeback to individual investigators. Essentially >95% of the usage of this Shared Resource is by Cancer Center members, and the great majority of their usage (90%) is for peer-reviewed funded projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-25S1
Application #
6610701
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-06-24
Project End
2007-02-28
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Scott, Jessica M; Li, Nan; Liu, Qi et al. (2018) Association of Exercise With Mortality in Adult Survivors of Childhood Cancer. JAMA Oncol 4:1352-1358
Rong, Yongqi; Bansal, Parmil K; Wei, Peng et al. (2018) Glycosylation of Cblns attenuates their receptor binding. Brain Res 1694:129-139
Levine, Jennifer M; Whitton, John A; Ginsberg, Jill P et al. (2018) Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 124:1044-1052
Li, Jian-Feng; Dai, Yu-Ting; Lilljebjörn, Henrik et al. (2018) Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci U S A 115:E11711-E11720
Sharma, Akshay; Kang, Guolian; Sunkara, Anusha et al. (2018) Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms. J Pediatr Hematol Oncol 40:e479-e485
Waszak, Sebastian M; Northcott, Paul A; Buchhalter, Ivo et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785-798
Zheng, Wenting; O'Hear, Carol E; Alli, Rajshekhar et al. (2018) PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells. Leukemia 32:1157-1167
Heikamp, Emily B; Pui, Ching-Hon (2018) Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia. J Pediatr 203:14-24.e2
Sadighi, Zsila S; Curtis, Elizabeth; Zabrowksi, Jennifer et al. (2018) Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatr Blood Cancer 65:e27063
Wierdl, Monika; Tsurkan, Lyudmila; Chi, Liying et al. (2018) Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemother Pharmacol 82:251-263

Showing the most recent 10 out of 6764 publications